Two Sigma Advisers
SRPT icon

Two Sigma Advisers’s Sarepta Therapeutics SRPT Stock Holding History

Two Sigma Advisers’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,071,334
Closed -$44.6M – 1856
2025
Q4 		$44.6M Buy
2,071,334
+113,300
+6% +$2.39M 0.09% 202
2025
Q3 		$37.7M Sell
1,958,034
-27,700
-1% -$494K 0.08% 211
2025
Q2 		$34M Buy
1,985,734
+1,709,400
+619% +$72.9M 0.07% 243
2025
Q1 		$17.6M Buy
+276,334
New +$29.1M 0.04% 363
2024
Q4 		– Sell
-128,034
Closed -$16M – 2521
2024
Q3 		$16M Sell
128,034
-478,800
-79% -$66.2M 0.04% 366
2024
Q2 		$95.9M Sell
606,834
-54,500
-8% -$7M 0.21% 97
2024
Q1 		$85.6M Sell
661,334
-44,800
-6% -$5.49M 0.2% 110
2023
Q4 		$68.1M Sell
706,134
-314,800
-31% -$30.2M 0.16% 136
2023
Q3 		$124M Sell
1,020,934
-238,500
-19% -$27M 0.32% 75
2023
Q2 		$144M Buy
1,259,434
+83,700
+7% +$10.8M 0.37% 75
2023
Q1 		$162M Buy
1,175,734
+566,100
+93% +$73.4M 0.42% 60
2022
Q4 		$79M Buy
609,634
+75,200
+14% +$8.71M 0.22% 100
2022
Q3 		$59.1M Buy
534,434
+256,000
+92% +$25.8M 0.17% 142
2022
Q2 		$20.9M Sell
278,434
-60,900
-18% -$4.48M 0.06% 318
2022
Q1 		$26.5M Sell
339,334
-117,100
-26% -$8.97M 0.07% 262
2021
Q4 		$41.1M Buy
+456,434
New +$39M 0.1% 178
2018
Q4 		– Sell
-17,792
Closed -$2.87M – 2450
2018
Q3 		$2.87M Sell
17,792
-67,900
-79% -$9.28M 0.01% 1054
2018
Q2 		$11.3M Buy
85,692
+48,834
+132% +$4.61M 0.03% 545
2018
Q1 		$2.73M Buy
+36,858
New +$2.46M 0.01% 1096
2016
Q4 		– Sell
-5,366
Closed -$330K – 2448
2016
Q3 		$330K Buy
+5,366
New +$162K ﹤0.01% 1850
2015
Q4 		– Sell
-28,166
Closed -$904K – 2012
2015
Q3 		$904K Buy
+28,166
New +$956K 0.01% 1047

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Advisers's SRPT Position: Q1 2026 in Review

Two Sigma Advisers sold out of Sarepta Therapeutics (SRPT) in Q1 2026, closing a stake of 2,071,334 shares — an estimated $44.6M sold.

Two Sigma Advisers first reported a position in SRPT in Q3 2015 and held it in 21 quarters. The position peaked at $162M in Q1 2023. 344 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.

  • Two Sigma Advisers reported no remaining Sarepta Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 2,071,334 Sarepta Therapeutics shares in Q1 2026, an estimated $44.6M.
  • Two Sigma Advisers first reported a position in Sarepta Therapeutics in Q3 2015 and held it in 21 quarters.
  • Two Sigma Advisers's Sarepta Therapeutics position peaked at $162M in Q1 2023.
  • 344 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.